About This Event

BioNTech SE (Nasdaq: BNTX, “BioNTech”), a global next generation immunotherapy company pioneering novel therapies for cancer and other serious diseases, visits the Nasdaq MarketSite in Times Square.

In honor of celebrating its fifth anniversary as a listed company, and ahead of its Innovation Series, R&D capital markets day, Prof. Ugur Sahin, MD, CEO and Co-Founder of BioNTech, rings the Opening Bell.